Notably, PGRN levels have been identified as significant predictors of risk in patients experiencing acute myocardial infarction, highlighting its potential as both a biomarker for cardiovascular disease severity and a therapeutic target for intervention [3]. The gene discussed is GRN; the disease is myocardial infarction.